Qritive makes cancer diagnosis fast, cheap, and accurate.

Qritive develops AI-powered solutions that enable histopathologic diagnosis of cancer at scale. Our clinical-decision support system for pathologists unlocks efficiency and quality gain in diagnosis, which results in better patient outcome. It includes AI Modules, an Image Management System platform (Pantheon), and a network of pathologists on-demand for services (annotations, 2nd opinion...) 
Our digital pathology platform has been used by several healthcare institutions in Singapore, India, Morocco, UAE, and USA, and the results have been presented at various events and journals: USCAP 2023 (deep learning on prostate biopsies), 2022 (Ki-67 on Sarcomas), and 2021 (colorectal malignancies), or Nature Scientific Report.

Biotechnology

Health Care

Health Diagnostics

Life Sciences

Medical Devices

Qritive

Qritive's headquarters in Singapore, Singapore

Bruno Occhipinti

Shriya Kumar

Sencer Karakaya

Kaveh Taghipour

Siew Kai C.

Description

People (1)

Bruno Occhipinti

Jobs